CJC-1295 (no DAC)

$45.00
DOSE
≥99% purity
Third-party tested
Ships from USA
Secure, discreet packaging
icon-delivery Delivery
  • Free shipping on orders $200+ (after discounts, before taxes).
    Flat rate shipping $15 on orders under $200.
    Estimated delivery time: 2–5 Business Days *
    Tracking provided once shipped.
Return Policy Learn More

CJC-1295 No DAC

CJC-1295 No DAC, also known as Modified GRF (1-29), is a synthetic growth hormone-releasing hormone analog studied for its relationship to pulsatile growth hormone signaling, pituitary receptor activity, and endocrine pathway research.

In research settings, CJC-1295 No DAC is commonly evaluated for its interaction with GHRH receptor pathways, pituitary signaling models, growth hormone pulse dynamics, IGF-1-related signaling, and endocrine regulation research.

Key Research Areas

  • GHRH receptor research involving pituitary signaling pathway analysis
  • Pulsatile growth hormone signaling and endocrine response models
  • IGF-1-related pathway research and downstream growth factor signaling
  • Metabolic research models involving hormone-regulated energy balance
  • Endocrine pathway modulation and hypothalamic-pituitary axis research

Mechanism of Interest

CJC-1295 No DAC is a modified GHRH (1-29) analog studied for its ability to interact with growth hormone-releasing hormone receptors. Research models evaluate how this interaction may influence pituitary signaling, growth hormone pulse activity, and downstream endocrine pathway communication.

Because it does not include DAC, CJC-1295 No DAC is often studied in models focused on shorter-duration, pulse-based signaling rather than extended-duration receptor activity.

Product Size: 5mg vial
Compound Class: Synthetic GHRH analog / Modified GRF (1-29)
CAS Number: 863288-34-0
Composition: CJC-1295 No DAC lyophilized peptide
Storage: Store lyophilized material in a cool, dry environment. Refrigeration is recommended after reconstitution.

Why Researchers Study CJC-1295 No DAC

CJC-1295 No DAC has gained interest in endocrine and growth hormone research due to its relationship with GHRH receptor activity, pituitary signaling, growth hormone pulse dynamics, and IGF-1-associated pathway analysis.

It is also commonly discussed in research contexts involving hypothalamic-pituitary axis models, metabolic signaling, hormone-regulated cellular activity, and pulse-based endocrine research.

Research Use Only:

This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.

Storage Information
Form: Lyophilized powder (white to off-white) Dry powder (unreconstituted): Stable at -20 °C for up to 24 months when kept sealed, dry, and protected from light Reconstituted solution: Store in sterile aliquots at -20 °C (up to 1 month) or -80 °C (longer term) Avoid repeated freeze–thaw cycles to maintain peptide integrity
CAS / Compound Information
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂ Molecular Weight: 3367.9 g/mol PubChem CID: 91976842 (alt: 56841945) CAS Number: 863288-34-0 Synonyms: CJC-1295 (No DAC), CJC-1295 without DAC, Mod GRF (1-29), Modified GRF 1-29, Tetrasubstituted GRF (1-29), GRF (1-29) analog

By Method Peptides